Sustainability | February 22, 2022
AstraZeneca partners with Honeywell to develop next-gen respiratory inhalers
New inhalers would have near-zero Global Warming Potential propellant
New inhalers would have near-zero Global Warming Potential propellant
ImmunIgY, has been developed by ReaGene Biosciences, Kyntox Bio and ProdigY, and is an antibody-containing beverage that can potentially prevent viral entry, regardless of vaccination or infection status
Market data indicates that more than twenty percent of the new chemical entities being developed use roller compaction technology in their development and commercialization
The total cost of the project is estimated at Rs 30 crore
The company plans to expand their capacity to meet the needs of pharma and biotech industries
Zydus Wellness Limited has reported consolidated financial results for the period ended September 30, 2021
The BiCNU brand and generic market had U.S. sales of approximately US $ 19.4 million MAT for the most recent twelve months ending in August 2021, according to IQVIA Health
It is one of the first companies to launch a bioequivalent version of the dry powder inhaler and it's part of the company’s strategic exclusive in-licensing arrangement to market Tiotropium DPI in Western Europe and the UK
A total of 8308 stores are open across India and medicines are priced at affordable rates
A high-value proposition recyclable film packed with industry-leading barrier and metal bond performance, sustainability quotient and U.S. FDA compliant
Subscribe To Our Newsletter & Stay Updated
